benzylamine has been researched along with Diabetic Retinopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bäcklund, LB; Ekblom, J; Garpenstrand, H; Oreland, L; Rosenqvist, U | 1 |
1 other study(ies) available for benzylamine and Diabetic Retinopathy
| Article | Year |
|---|---|
Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy.
Topics: Amine Oxidase (Copper-Containing); Benzylamines; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycated Hemoglobin; Humans; Linear Models; Male; Middle Aged | 1999 |